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Abstract
Background: Hypoxemia may occur in young infants with severe acute illnesses or congenital cardiac anomalies,
but is not reliably detected on physical exam. Pulse oximetry (PO) can be used to detect hypoxemia, but its
application in low-income countries has been limited, and its feasibility in the routine assessment of young infants
(aged 0–59 days) has not been previously studied. The aim of this study was to characterize the operational
feasibility and parent/guardian acceptability of incorporating PO into the routine clinical assessment of young
infants in a primary care setting in a low-income country.
Methods: This was a cross-sectional study of 862 visits by 529 infants at two primary care clinics in Karachi, Pakistan
(March to June, 2013). After clinical assessment, oxygen saturation (Sp02) was measured by a handheld PO device
(Rad-5v, Masimo Corporation) according to a standardized protocol. Performance time (PT) was the time between
sensor placement and attainment of an acceptable PO reading (i.e., stable SpO2 + 1 % for at least 10 s, heart rate
displayed, and adequate signal indicators). PT included the time for one repeat attempt at a different anatomical site
if the first attempt did not yield an acceptable reading within 1 min. Parent/guardian acceptability of PO was based
on a questionnaire and unprompted comments about the procedure. All infants underwent physician assessment.
Results: Acceptable PO readings were obtained in ≤1 and ≤5 min at 94.4 % and 99.8 % of visits, respectively (n = 862).
Median PT was 42 s (interquartile range 37; 50). Parents/guardians overwhelmingly accepted PO (99.6 % overall
satisfaction, n = 528 first visits). Of 10 infants with at least one visit with Sp02 <92 % on a first PO attempt, 3 did not
have a significant acute illness on physician assessment. There were no PO-related adverse events.
Discussion: Using a commercially available handheld pulse oximeter, acceptable Sp02 measurements were obtained
in nearly all infants in under 1 minute. The procedure was readily integrated into existing assessment pathways and
parents/guardians had positive views of the technology.
Conclusions: When incorporated into routine clinical assessment of young infants at primary care clinics in a low-income
country, PO was feasible and acceptable to parents/guardians. Future research is needed to determine if the introduction
of routine PO screening of young infants will improve outcomes in low-resource settings.
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Background
Timely management of severe neonatal infections (e.g.,
sepsis, pneumonia) is a crucial component of public
health strategies to reduce infant mortality in low-
income regions [1]. Although community health workers
(CHWs) can be trained to recognize signs of illness in
young infants (aged 0 to 59 days), appropriate triage and
referral of the most critically ill infants relies on the
recognition of signs of early or impending cardiorespira-
tory failure, including hypoxemia [2, 3]. Existing clinical
algorithms based on signs and symptoms, such as the
World Health Organization (WHO)/UNICEF Integrated
Management of Childhood Illness (IMCI) approach, are
insensitive for detecting hypoxemia in infants and young
children [4].
Pulse oximetry (PO) is an non-invasive method of
measuring peripheral oxygen saturation (SpO2) based
on the differential absorption of red versus infrared light
by oxygenated hemoglobin in a narrow tissue segment
(e.g. infant’s hand or foot) [5]. The use of PO to evaluate
cardiorespiratory function is nearly universal in health
care settings in high-income countries, and has been ac-
cepted as a ‘fifth vital sign’ in pediatrics [6, 7]. Although
there are few published studies of the added clinical
value of routine PO in pediatric ambulatory or emergency
care settings, studies in the US have provided evidence
that routine PO may enable more effective triaging of
children presenting with lower respiratory tract infections
[8, 9]. Pulse oximetry has also recently been shown to be
effective as a screening tool for early detection of critical
congenital heart disease [10].
In primary care clinics where acute illnesses are triaged
and managed, PO may be particularly useful in young in-
fants (<2 months of age), among whom clinical features of
serious illness are often subtle and non-specific. However,
PO has infrequently been implemented in primary care
clinics in low-income countries due to a range of both real
and perceived barriers, including the availability and field ro-
bustness of low-cost PO devices, the time required to per-
form PO, and the challenges of accurate interpretation of
PO readings by minimally-trained personnel (e.g., identifica-
tion of motion artifacts or rejection of a spurious result due
to a poor signal) [7]. Although there is emerging evidence
that use of PO coupled with supplemental oxygen availabil-
ity can improve hospital care delivery and outcomes, there
is limited published experience related to the use of PO in
the routine assessment of young infants (<2 months of age)
in primary care clinics in low-income countries [11]. In the
present study, we assessed the implementation of PO as a
triage tool for young infants assessed at primary care clinics
in Karachi, Pakistan. The aim was to determine if integration
of PO into the routine assessment of young infants by
CHWs is a practice that can be feasibly operationalized, is
acceptable to parents/guardians, and provides clinical value.
Methods
Study setting and design
We conducted a cross-sectional facility-based study be-
tween March 5th and June 1st, 2013 at two primary care
clinics in low-income communities of Karachi, Pakistan.
The Bilal Colony (Site 1) primary care clinic serves a
population of 70 000, with approximately 40 young
infant visits per week. The Bhains Colony (Site 2) pri-
mary care clinic serves a population of approximately 40
000, with 30 young infant visits per week. Both clinics
provide well-child care (vaccination, growth monitoring,
nutrition and hygiene education) and outpatient care for
common childhood illnesses. A team of community
health workers add outreach capacity through regular
visits to households to detect early symptoms of illness
such as newborn sepsis, and refer ill infants to these
clinics for physician assessment. Seriously ill infants and
children are provided transport to hospital or in case of
refusal, centre-based parenteral antibiotic therapy (if indi-
cated). Both sites are approximately located at sea level.
Study procedures were performed by a pair of study
personnel – a study worker and a research assistant.
Each clinic site was served by a core team of two study
workers and one research assistant. Less than 2 % of the
visits involved other trained personnel substituting for a
core team member. “Study workers” refer to the four
personnel (two at each clinic) who directly assessed
infants according to the IMCI algorithm, performed
pulse oximetry and conducted the initial infant parents/
guardian interview. These individuals had secondary
school education and prior experience in health research
projects involving infants and children, but they did not
have professional research or health care credentials. We
considered their level of training/experience to be similar
to that of a CHW. ‘Research assistants’ (one at each clinic)
coordinated study activities, observed study workers to
record data related to timing of pulse oximetry, and con-
ducted an exit interview with parents/guardians. Research
assistants had post-secondary education and had long-
standing professional involvement in research as em-
ployees of Aga Khan University. All personnel were
trained in formal sessions as well as a pilot implementa-
tion phase. None of the team members had used a pulse
oximeter prior to this training/pilot period.
All visits by infants 0 to 59 days of age were eligible
for inclusion, unless the infant was attending the clinic
solely for a scheduled injectable antibiotic administration
based on a previous diagnosis of suspected bacterial in-
fection, or was too sick to undergo study procedures
(because of the risk of delaying medical care). Infants
were initially assessed by a Lady Health Worker (LHW,
a government trained health worker) according to rou-
tine clinic intake procedures, including measurement of
weight and axillary temperature. Eligible infants were
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then referred to the PO study team who obtained informed
consent from the parent or guardian (that is, the infant’s
caregiver in place of a parent) prior to proceeding with
study procedures. Critically ill infants were referred directly
to a clinic physician. Infants with previous study visits were
eligible for an unlimited number of ‘revisits’ (i.e., second
and subsequent visits).
The protocol was conducted in compliance with the
Declaration of Helsinki and the protocol was approved
research ethics committees at the Aga Khan University
(Protocol No. 2006-Ped-ERC-11) and the Hospital for Sick
Children (Protocol No. 1000028096). Written informed
consent was obtained from all parents/guardians.
Procedures
A structured parent/guardian interview was conducted by
the study worker to elicit sociodemographic information,
reason for clinic visit, and the parent/guardian perception
of the infant’s illness severity. Enrolled infants underwent
clinical assessment by the study worker according to the
IMCI protocol, including enquiry about a history of
convulsions or poor feeding, measurement of axillary
temperature (if not already done by LHW) to determine
presence of fever (>37.5 °C), counting of respiratory rate
(RR) over 1 min (fast breathing defined as RR ≥ 60), obser-
vation for the presence of lower chest wall in-drawing,
and determination of the level of consciousness/move-
ment [3, 12].
Following the IMCI assessment, conducted by the study
worker, SpO2 was measured using a commercially-
available handheld PO device widely used in pediatric
practice (Rad-5v, Masimo Corporation, Irvine, California),
applying the low noise cabled sensor (LNCS) YI sensor
(Masimo Corporation, Irvine, CA) to a left foot (first
attempt) or right palm (second attempt, if needed) and
secured in place using a reusable foam wrap, according to
the manufacturer’s recommendation. First, the sensor
(connected to the oximeter via an extension cable) was
placed on the infant and subsequently, the oximeter was
powered-on, an approach similar to that which has been
previously referred to as “sensor to infant first” [13]. The
Sp02 reading was considered “acceptable” if the measured
SpO2 was stable (±1 %) for at least 10 s, the heart rate was
displayed during the period of SpO2 measurement and the
device’s functional indicators (‘blip bars’) suggested that
the signal strength was adequate (i.e., green signal). If
1 min passed without obtaining an acceptable reading, the
sensor was moved to the alternate site and the PO meas-
urement was re-attempted. If five minutes passed without
obtaining an acceptable reading, the measurement was
considered attempted but unsuccessful. If an acceptable
Sp02 was <90 %, the measurement was repeated to con-
firm the low value. Infants with Sp02 <90 % were offered
referral to a tertiary health facility, regardless of the
presence of other clinical signs. While the study worker
performed the PO procedure, a research assistant ob-
served and recorded the procedure time, Sp02, heart rate,
and signal strength indicators displayed at the time the
reading was deemed to be acceptable by the study worker.
The study worker also recorded any spontaneous verbal
comments by parents/guardians regarding the procedure
(e.g., concerns about infant discomfort).
Infants were subsequently referred to a clinic physician,
who completed a history and physical examination, and
determined whether the infant required clinic-based treat-
ment or immediate referral to hospital. To the extent that
it was possible, the physician was not informed of the
Sp02 prior to the determination of hospital referral. For 8
of 862 readings (0.9 %), blinding was not achieved, such
that the physician knew of the SpO2 reading before
making a decision regarding the need for hospital referral.
Five of the 8 unmasked readings had SpO2 <90 %; in these
cases, the physician was informed of the PO results to
expedite clinical management. After completion of clinical
and PO procedures, parents/guardians were asked to
participate in a brief structured interview regarding per-
ceptions and acceptance of PO.
Following the initial standardized PO procedure with
the Rad-5v, PO was repeated using one of three other
handheld PO devices: Lifebox (Acare Technology Co. Ltd.,
Taipei City, Taiwan), Tuffsat (General Electric Corpor-
ation, Fairfield, CO), or Nellcor OxiMax N-65 (Covidien
Corporation, Mansfield, MA). The original intention was
to establish feasibility on a variety of hand-held oximeters;
however, we made a post-hoc decision to exclude data for
these additional devices from the present analysis, for
several reasons: these devices were each used less fre-
quently than the Rad-5v such that personnel did not have
comparable time to develop comfort and competence with
their use; the secondary devices were not consistently used
in both clinics and therefore were used by different
personnel and among different patient populations
(Table 1); measurements with the Rad-5v device always
preceded the use of the secondary devices, such that in-
fants may have been relatively more unsettled and
personnel may have felt rushed during this second set of
PO measurements.
Outcome measures
The primary feasibility metric was the “performance
time” (PT), in seconds, defined as the total time required
to obtain an acceptable reading from the initiation of the
procedure (when the study worker first picked up the
sensor to place it on the infant) until an acceptable read-
ing was obtained (study worker recorded a SpO2 value
on the data form). The ‘lag time’ (LT), in seconds, was
defined as the period from pressing the power button on
the device until an acceptable reading was obtained.
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Whereas PT incorporated both personnel and device
performance factors, the LT (a component of PT) pri-
marily reflected device factors. Both PT and LT included
the 10 s required to confirm that the displayed Sp02 was
stable (criterion for acceptable reading). Parent/guardian
perceptions of PO were measured by yes/no responses
to a series of prompted items regarding overall satisfac-
tion, openness to PO in the future, perceived usefulness,
and concerns about infant discomfort. Unprompted
parent/guardian concerns were also included in accept-
ability analyses.
To summarize acceptable Sp02 values, we considered
that if the measurement was repeated because the initial
attempt yielded an acceptable Sp02 <90 %, and the second
attempt also yielded an acceptable reading, the higher of
the two acceptable Sp02 values was included in descriptive
analyses. However, the time to the first acceptable reading
was used in analyses of the feasibility outcomes (PT and
LT). In the original design of this study, we had aimed to
explore the clinical utility of PO through analyses of the
association of hypoxemia (Sp02 <90 %, per the WHO
threshold [14]) with infant clinical outcomes; however,
the prevalence of hypoxemia was much lower than
anticipated, and such analyses were not feasible within
the current dataset. Instead, as a post-hoc descriptive
analysis, we summarized the clinical information for
infants with any acceptable Sp02 <92 % (a threshold for
hypoxemia often used in clinical practice [15]) at any
visit, including the range of Sp02 at all the infants’
visits, IMCI assessment by the study worker and
physician diagnosis at the visit at which hypoxemia
was first detected, and vital status at 2 months of age
(if available).
Statistical analysis
Descriptive statistics included median (interquartile
range, IQR) for non-normally-distributed variables
and proportions for dichotomous/categorical variables.
We considered feasibility in terms of the median PT
and LT, as well as the proportion of acceptable read-
ings obtained within 1 min (primary target) and
5 min. We investigated whether the feasibility out-
comes (PT and percent acceptable readings within
1 min) were significantly associated with any of the
following factors: clinic site, day of visit relative to
the start of the study, age, sex, weight, reason for
Table 1 Characteristics of young infants undergoing routine pulse oximetry at initial study visits and revisits at primary care clinics in
Karachi, Pakistan, stratified by study site
Characteristic Total Initial visits Revisits
Initial visits Revisits Site 1 Site 2 p Site 1 Site 2 p
Number of visits (n) 529 333 299 230 182 151
Sex
Male 267 (50.5 %) 186 (55.9 %) 153 (51.2 %) 114 (49.6 %) p=0.71 103 (56.6 %) 83 (55.0 %) p=0.77
Female 262 (49.5 %) 147 (44.1 %) 146 (48.8 %) 116 (50.4 %) 79 (43.4 %) 68 (45.0 %)
Age
0-6 days 177 (33.5 %) 32 (9.6 %) 123 (41.1 %) 54 (23.5 %) p<0.001 18 (9.9 %) 14 (9.3 %) p=0.12
7-29 days 176 (33.3 %) 160 (48.0 %) 95 (31.8 %) 81 (35.2 %) 96 (52.8 %) 64 (42.3 %)
30-59 days 176 (33.3 %) 141 (42.3 %) 81 (27.1 %) 95 (41.3 %) 68 (37.4 %) 73 (48.3 %)
Visit reasona
Well baby visitb 97 (18.3 %) 26 (7.8 %) 77 (25.8 %) 20 (8.7 %) p<0.001 22 (12.1 %) 4 (2.7 %) p<0.001
Referred for new illness 424 (80.2 %) 209 (62.8 %) 222 (74.3 %) 202 (87.8 %) 154 (84.6 %) 55 (36.4 %)
Follow-up visit for illness 8 (1.5 %) 72 (21.6 %) 0 (0 %) 8 (3.5 %) 6 (3.3 %) 91 (60.3 %)
Parent/guardian’s perception of infant’s illness severityc
Healthy 101 (19.1 %) 26 (7.8 %) 79 (26.4 %) 22 (9.6 %) p<0.001 22 (12.1 %) 4 (2.7 %) p<0.001
Minor illness 406 (76.8 %) 288 (86.5 %) 203 (67.9 %) 203 (88.3 %) 145 (79.7 %) 143 (94.7 %)
Very sick 6 (1.1 %) 8 (2.4 %) 5 (1.7 %) 1 (0.4 %) 7 (3.9 %) 1 (0.7 %)
Life-threatening 2 (0.4 %) 0 (0 %) 2 (0.7 %) 0 (0 %) 0 (0 %) 0 (0 %)
Physician recommended referral to hospital?
Yes 62 (11.7 %) 48 (14.4 %) 22 (7.4 %) 40 (17.4 %) p=0.001 19 (10.4 %) 29 (19.2 %) p=0.03
No 467 (88.3 %) 285 (85.6 %) 277 (92.6 %) 190 (82.6 %) 163 (89.6 %) 122 (80.8 %)
an = 150 because one infant’s reason for a Site 2 revisit was missing
bWell baby visit refers to a visit for well-child care (vaccination, growth monitoring, nutrition and hygiene education)
cParent/guardian perceptions of infant illness severity were missing at 25 visits (2.9 %)
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visit and presence/absence of at least one IMCI
criteria. Differences in PT across strata (e.g., between
age groups,) were assessed using non-parametric test-
ing (Wilcoxon rank-sum tests). Associations between
PT and continuous covariates (e.g., age) were also an-
alyzed using Spearmen’s rank correlation coefficient.
Differences in proportions (i.e. % of readings obtained
within 1 min, baseline participant characteristics and
parent/guardian acceptability metrics) were analyzed
by Chi-squared tests. Because clinic site was a strong
predictor of PT, analyses for other factors were
performed after stratification by site. Among infants
with >1 visit during the study period, there was no
correlation between PT at initial and first revisits
(Spearmen’s Rho = 0.0518, p = 0.4938, n = 177). There-
fore, visits by the same infant were treated independ-
ently in analyses of feasibility metrics.
Results
Of 1166 visits screened for eligibility during the study
period, 1084 (93 %) were eligible for inclusion and 862
(74 %) were enrolled. Of 222 ineligible visits, five
involved critically ill infants who required immediate
medical management. Of the 862 included visits, 529
(61 %) were infants’ initial visits included in the study
and 333 (39 %) were revisits. Characteristics of the visits
and revisits differed between the two study sites with
respect to age distribution, reason for visit, and parent/
guardian perception of illness severity (Table 1).
Acceptable PO readings were obtained in ≤1 and ≤5 min
at 94.4 % and 99.8 % of visits, respectively (n = 862). The
median PT was 42 s (IQR 37; 50) and median LT was 34 s
(IQR 29;40). The proportion of visits with acceptable
readings increased rapidly within the first minute; in com-
parison, the rate of increase in the proportion of infants
with acceptable readings during second attempts was rela-
tively slower (Fig. 1).
Among the 48 (of 862) visits at which the first attempt
was unsuccessful (i.e., reading was not obtained within
1 min), all (100 %) showed poor quality signals according
to the device indicator, 87 % had SpO2 values that were
fluctuating between at least 2 values, and 40 % did not dis-
play a heart rate value.
The distribution of PT differed significantly across sites,
even after stratification by infant characteristics (Table 2).
In stratified analyses by site, we did not identify any infant
characteristics that were significantly associated with PT
(Table 2). However, the proportion of acceptable readings
obtained in 1 min was significantly greater in the younger
age group (0 – 29 days) than in the older age group (30 –
59 days) at Site 2. There was some evidence that accept-
able readings were obtained slightly more rapidly as the
study progressed, but this did not lead to an increase in
the proportion of readings obtained in 1 min (Table 2).
PO was widely accepted by parents/guardians, even at
repeated encounters (Table 3). A very small number of par-
ents/guardians perceived that the PO sensor caused pain
or discomfort to the infant or that the duration of testing
was too long (Table 3). No adverse events were reported.
At 529 initial visits, 528 infants had acceptable SpO2
measurements that ranged from 72 % to 100 %, with the
majority between 90 and 100 % (median 99 %, IQR 97 %
to 100 %) (Fig. 2). There were only 2 initial visits at
which SpO2 values were <90 %, but 40 (7.6 %) at which
SpO2 < 95 % (a cut-off commonly used for congenital
heart disease screening).
Fig. 1 Cumulative proportion of participants with acceptable oxygen saturation (Sp02) values over time, among young infants undergoing routine
pulse oximetry at primary health centers in Karachi, Pakistan. Time shown represents pulse oximetry “performance time” (see text for definition)
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Ten infants with at least one acceptable Sp02 < 92 % at
any visit (initial or revisit) contributed a total of 37 visits;
SpO2 < 92 % occurred at 13 of 37 (35 %) visits (Table 4).
Sp02 was ≥92 % at 2 of the 4 visits at which the first
Sp02 < 92 % and there was a repeat attempt at the same
visit (Table 4). For example, infant #5 was enrolled in
the study at age 3 days, at which time Sp02 was 84 %;
however, a repeat measurement during the same visit
indicated a Sp02 of 94 %. Further SpO2 measurements
at two subsequent revisits were >92 % and the infant
was alive and well at the end of follow-up at 2 months
of age. Of the 3 (of 10) infants who were not considered to
be significantly unwell according to IMCI criteria or phys-
ician assessment at the time of first detection of Sp02 <
92 % (Table 4), outcomes were as follows: infant #4, died of
unknown cause at 2 weeks of age (described below), infant
#7 was reportedly well at 2 months of age, and infant #10
was lost to follow-up (Table 4). Although most of the in-
fants with Sp02 <92 % had good clinical outcomes docu-
mented at two months of age, there were two infants with
adverse sequelae. Infant #3, who was enrolled in the study
during five visits from 10 to 42 days of age, had SpO2
Table 2 Pulse oximetry performance time and proportion of acceptable readings obtained within 1 min by site and by infant
characteristics among young infants undergoing routine pulse oximetry at primary care clinics in Karachi, Pakistan
Performance time (seconds), median (IQR) Acceptable Sp02 value obtained in≤ 1 min, % (n)
Site 1 Site 2 p Site 1 Site 2 p
Number of visits 481 381 - 481 381 -
Overall 44(39;50) 40(35;46) <0.0001 94.4(454) 94.5(360) 0.9485
Age (days)a
0 – 29 43(39;50) 40(34;45) <0.0001 95.5(317) 98.1(209) 0.1011
30 – 59 45(40;51) 39.5(35;49.5) <0.0001 91.5(137) 89.9(151) 0.5244
p 0.0771 0.2127 0.1193 0.0005
Sex
Male 44(39;50) 38(35;46) <0.0001 95.3(244) 95.4(188) 0.9524
Female 44(40;50) 40(35;45) <0.0001 93.3(210) 93.5(172) 0.9532
p 0.7880 0.6813 0.3467 0.4038
Weight (g)b
980 - 3319 43(39;50) 40(35;45) <0.0001 94.2(242) 96.5(166) 0.2693
3320 – 5900 45(39.5;50) 39(35;49) <0.0001 94.6(212) 92.8(194) 0.4339
p 0.5961 0.5959 0.8197 0.1164
Reason for visitc
Well baby 43(39;49) 40(35;44) 0.0225 95.0(94) 95.8(23) 0.8569
Visit foriIllness 44(39;50) 39(35;46) <0.0001 94.2(360) 94.4(336) 0.9341
p 0.2563 0.8513 0.7849 0.7633
At least one IMCI criteriond
No 44(39;50) 39(34;45) <0.0001 94.0(331) 95.2(260) 0.5104
Yes 45(39;50) 40(35;47.5) 0.0022 95.4(123) 92.6(100) 0.3701
p 0.8151 0.1584 0.5789 0.3078
Time since start of study periode
First period 45(40;50) 40(36;45) p < 0.0001 97.1(233) 94.6(176) 0.1983
Second period 43(39;51) 38(33;46) p < 0.0001 91.7(221) 94.4(184) 0.2830
p 0.4007 0.0190 0.0103 0.9099
aAge in days categorized based on median. Correlation between performance time and age was also analyzed as a continuous variable: Site 1- Spearman’s
Rho = 0.0927, p = 0.0422; Site 2- Spearman’s Rho = 0.0556, p = 0.2791
bWeight in grams categorized based on median. Correlation between performance time and weight was also analyzed as a continuous variable: Site 1- Spearman’s
Rho = 0.0625, p = 0.1710; Site 2- Spearman’s Rho = 0.0297, p = 0.5627
cn = 861. One reason for visit was listed as “other”, and was excluded from these analyses
dIntegrated management of childhood illness (IMCI) criteria assessed by the study worker: Temperature < 35.5 °C, temperature > 37.5 °C, respiratory rate ≥ 60,
severe lower chest wall in-drawing, no movement or movement only on stimulation, observed convulsions, history of convulsions, history of poor feeding
eDate of visit was used to categorize visits into study periods. First period included the first half of measurements for each site, while second period included the
second half of measurements for each site. Correlation between performance time and time since start of the study was also analyzed as a continuous variable:
Site 1- Spearman’s Rho = −0.0396, p = 0.3865; Site 2- Spearman’s Rho = −0.1809, p = 0.0004
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Table 3 Acceptability of pulse oximetry to parents/guardians of young infants undergoing routine pulse oximetry at primary care
clinics in Karachi, Pakistan
Concern Initial Visit Revisit p1
Were you satisfied with the oxygen test? n = 528 n = 333
Yes 527 (99.8 %) 333 (100 %) p = 1.0
No 1 (0.2 %) 0 (0 %)
Would you permit the oxygen test to be performed on your baby again in the future? n = 512 n = 328
Yes 509 (99.4 %) 328 (100 %) p = 0.29
No 3 (0.6 %) 0 (0 %)
Do you believe the oxygen test was useful for the nurses/doctors to check your baby? n = 526 n = 333
Yes 526 (100 %) 333 (100 %) p = 1.0
No 0 (0 %) 0 (0 %)
Did the parent/guardian express unprompted concerns about: n = 527 n = 333
Pain/discomfort
Yes 27 (5.1 %) 4 (1.2 %) p = 0.002
No 500 (94.9 %) 329 (98.8 %)
Heat/burning
Yes 1 (0.2 %) 0 (0 %) p = 1.0
No 526 (99.8 %) 333 (100 %)
Sensor was wrapped too tightly
Yes 0 (0 %) 0 (0 %) p = 1.0
No 527 (100 %) 333 (100 %)
Test was taking too long
Yes 0 (0 %) 0 (0 %) p = 1.0
No 527 (100 %) 333 (100 %)
1P value for Fisher’s exact test of difference in proportions between initial visits and revisits
Fig. 2 Proportion of infants with measured Sp02 at initial study visits. One infant without an acceptable Sp02 measurement at the initial study
visit was excluded from this analysis (n = 528)
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<92 % measured repeatedly starting at the third visit (age
37 days). Based on the low Sp02 in combination with the
presence of a cardiac murmur, echocardiography was ar-
ranged and revealed a diagnosis of tetralogy of Fallot with
pulmonary atresia. The infant was referred for specialist
pediatric cardiac care and surgical correction. Infant #4
was enrolled at 7 days of age during a well baby visit, at
which time SpO2 was 84 % and 91 % based on consecutive
measurements. The physician assessed the infant as gener-
ally well-appearing and not meeting IMCI criteria for refer-
ral; however, ten days after participation in the study, the
infant died at home of an unknown cause (inconclusive
verbal autopsy).
Discussion
This observational study demonstrated the operational
feasibility and parent/guardian acceptability of PO ‘spot
checks’ in the routine clinical assessment of young infants
at two primary care clinics in low-income communities of
Karachi, Pakistan. Using a commercially available hand-
held device and a sensor-to-infant-first technique, accept-
able Sp02 measurements were obtained in nearly all
infants in under 1 min, from the time of initiating sensor
placement to the display of a stable Sp02 value. The pro-
cedure was readily integrated into existing assessment
pathways and was well tolerated by the infants. Addition-
ally, parents/guardians had positive views of the technol-
ogy at nearly all visits. These findings provide a practical
basis for further research assessing the clinical effective-
ness of PO in the triage and management of young infants
in low-income settings.
PO is a painless and portable technology that is widely
used in pediatric practice to non-invasively assess and
monitor cardiorespiratory function, particularly in
perioperative care, emergency departments, critical
care units, and in the management of patients with
acute or chronic respiratory disease [16]. Despite the
availability of PO devices in healthcare facilities, there
has not been a strong rationale for its application as
a routine ambulatory screening or triage tool because
most children and adolescents with hypoxemia will
exhibit at least one sign of respiratory distress, cyan-
osis, or abnormal findings on pulmonary ausculation
[17]. However, young infants (<2 months of age) often
have subtle and protean presentations of infectious,
pulmonary and cardiac diseases [3], and there is par-
ticularly poor accuracy of clinical signs for detecting
hypoxemia in this age group [4, 18, 19]. Studies in
low-income settings have documented Sp02 < 90 % in
about one-fifth of hospitalized newborns (irrespective
of specific diagnosis), suggesting a higher burden of
hypoxemia in this group than among older children
with pneumonia, although thresholds for hypoxemia
vary by altitude [20] Moreover, studies in Kenya [19]
and Papua New Guinea [4] have demonstrated a ro-
bust association between hypoxemia and mortality in
neonates. Because of the importance of avoiding de-
lays in initiating treatment and appropriate referral of
sick young infants, there may be a public health
benefit of introducing PO screening in the routine
clinical assessment of young infants [5]. In some
high-income countries, PO has been recently recom-
mended for the routine screening of all healthy new-
borns in the early postnatal period (prior to discharge
from hospital) for the purpose of detecting critical
congenital heart disease [21], However, we are not
Table 4 Oxygen saturation (SpO2) and clinical outcomes of participants with at least one SpO2 < 92 % at any study visit among














59 days of age
1 3 72 - RR, NM Acute respiratory infection 1 N/A Alive
2 5 73 99 RR, NM Sepsis 5 91 – 99 Alive
3 37 87 88 RR Acute respiratory infection,
congenital heart disease
5 82 – 93 Alive
4 7 84 91 None No acute illness 1 N/A Deceased
5 3 84 94 None Hyperbilirubinemia 3 97 – 99 Alive
6 1 86 - RR Acute respiratory infection 10 93 – 100 Alive
7 0 90 - None No acute illness 1 N/A Alive
8 1 91 - FVR, RR,
LCI, PF
Sepsis 5 94 – 100 Alive
9 14 91 - RR, LCI Sepsis 4 97 Alive
10 2 91 - None No acute illness 2 97 Lost to follow Up
aRefers to first clinic visit at which hypoxemia (SpO2 < 92 %) was detected for each infant
bIntegrated management of childhood illness (IMCI) algorithm signs of very severe disease in a young infant, as detected by the study worker: RR = Respiratory
rate ≥ 60; NM = No movement or movement only on stimulation; FVR = Fever; LCI = Severe lower chest wall in-drawing; PF = History of poor feeding
cRefers to other clinic visits by the same infant during first 2 months of life
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aware of previous studies of the implementation of
routine PO as a screening tool beyond the immediate
newborn period.
The widespread implementation of PO in low-income
countries remains limited, due in part to practical bar-
riers including lack of access to functioning devices and
insufficient training in use of the technology [22]. Where
PO devices are available, they are prioritized for use in
operating rooms and for rationing supplemental oxygen
supplies among patients hospitalized with pneumonia
[5]. However, the present study confirmed our hypoth-
esis that modern portable PO technology coupled with a
standardized approach by trained personnel would en-
able this technology to be readily incorporated into the
IMCI young infant assessment with minimal burden to
the health worker and near universal acceptance by
parents/guardians. We did not identify specific infant
characteristics (e.g., age) that consistently and substan-
tially affected the primary feasibility metric, PT and suc-
cess within 1 min. Moreover, there was no correlation
between PT at first and second visits by the same infant,
indicating the low likelihood that fixed infant characteris-
tics affected PO success. However, significant differences
in PT and success by 1 min between the two clinic sites
highlighted the importance of considering personnel/sys-
tem-level factors (e.g., competence of PO operators) that
may impact on PO feasibility.
In-hospital implementation of PO has been previously
described in The Gambia [23] and Papua New Guinea
[11], but we are unaware of any studies of PO feasibility
in a primary health care setting in a low-income country.
Louis et al. (2014) recently compared two methods of
applying PO during resuscitation of newborns in the de-
livery room at a hospital in northern India, using a
Masimo oximeter that uses the same algorithm as the
device employed in the present study [13]. With a sensor
to infant first approach, they reported high success rates
and a median lag time of 16 s. However, a sensor to
oximeter first approach, whereby the PO device was left
powered-on and attached to the sensor before the sensor
was applied to the infant, had a significantly faster lag
time [13]. We selected the traditional sensor to infant
first approach on the rationale that it prevents the oximeter
from averaging ambient noise during the period immedi-
ately preceding sensor placement, and would therefore
reduce the time to acquire an artifact-free signal [24]. How-
ever, Louis et al. argued that modern oximeters have rapid
averaging times (~2 s) that avoid such artifacts [13]. There-
fore, adoption of a sensor to oximeter approach may have
further reduced the performance time in our study setting.
Not unexpectedly, we observed a much lower preva-
lence of hypoxemia in a primary care setting compared
to rates reported in hospital-based studies [20]. Even
among the few encounters at which Sp02 < 92 % were
detected, the reliability of the majority of those measure-
ments were questioned because of normal repeated mea-
surements or the absence of clinical sequelae. Although
we were thus unable to draw firm conclusions about the
clinical utility of routine PO from the present study, we
did observe a role of PO in the detection of at least one
case of major congenital cardiac disease, and potential
contributions of PO to the assessment of disease severity
in some infants with acute respiratory infections. The
clinical effectiveness of routine or targeted PO in this
setting would depend on the specific adverse outcomes
that the health system in which PO is being undertaken
is able to avert. For example, in the absence of a suffi-
ciently developed health system that could accommodate
referral of otherwise asymptomatic infants with hypox-
emia for echocardiogram (to rule-out congenital heart
disease), it may be more rational to target PO to sick
infants. Yet, even if PO is reserved for infants with clin-
ically suspected sepsis or respiratory diseases, its value
would depend on the efficiency of referral systems and
availability of supplemental oxygen supplies.
The protocol for Sp02 spot checks in this study was
intended to simulate a practice that could be realistically
introduced into a variety of primary care settings. Pulse
oximeters were used by first-level personnel (a cadre
with less health care training and experience than
nurses), but because staff had substantial opportunities
for training and practice, and were highly motivated
throughout the study, they may not be representative of
health care workers who would implement routine pulse
oximetry outside of a research context. The small number
of study workers who were trained to use pulse oximetry
limited the analysis of worker, clinic and system-level fac-
tors that may have impacted the performance and feasibil-
ity of pulse oximetry in this setting, and which likely
accounted for the observed between-site differences. A
limitation of the Sp02 interpretation was that the criteria
for acceptable readings were based only on information
displayed in real-time by the handheld oximeter (e.g.,
stable Sp02, heart rate, and blip bar signal indicators). Al-
though we used a device that employs a motion-resistant
algorithm that has been validated and widely implemented
in neonatology [25, 26], it is optimal if operators confirm
regular rhythms by monitoring plethysmographic wave-
forms [16], which would likely not be feasible in routine
clinical practice. An inherent threat to the reliability of
Sp02 measurement is that PO devices tend to slightly
overestimate Sp02 relative to arterial oxygen saturation
measured by co-oximetry, and precision and accuracy vary
through the Sp02 range [27]. Indeed, the most common
SpO2 observed in this study was 100 %, greater than the
median 97 % commonly observed at sea level in well neo-
nates [28]. Therefore, it is likely that some infants with
mild hypoxemia would not be correctly identified as such
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using PO. Furthermore, the criteria used in this study to de-
fine an acceptable Sp02 (including a stable reading with
variation within ±1 % over 10 s) were intended to
standardize the procedure in a manner that could be feas-
ibly adopted in routine practice; however, the criteria may
have been too restrictive (e.g., excluded readings that were
clinically meaningful) and likely included some readings
that were unreliable (i.e., met criteria despite an inconsist-
ent underlying waveform). Validation of device-specific ‘ac-
ceptability criteria’ for field applications should be a priority
of future research.
Future research efforts should aim to establish the condi-
tions under which the introduction of PO into primary care
settings improves health outcomes, ideally in conjunction
with supplemental oxygen availability. For example, PO may
improve clinical outcomes of ill neonates by improving the
rational allocation of supplemental oxygen, prompting ap-
propriate referrals to hospital, and identifying infants who
warrant further investigations (e.g., echocardiography). Stud-
ies should ideally measure PO feasibility and identify
context-specific barriers to implementation and scale-up, in-
cluding long-term robustness of PO devices and compo-
nents, data that we did not report because of the relatively
short duration of this study. In addition to the initial cost of
the devices, the high cost of repair and replacement of
minor components, such as sensors and cables, is likely to
be an important barrier to PO implementation in develop-
ing countries [5].
Conclusions
There is a growing literature suggesting that PO is feasible
and improves clinical care of children in low resource
settings [5]. The present study adds to this evidence base,
by demonstrating the feasibility and acceptability of rou-
tine PO in the assessment of young infants at primary care
clinics. However, its clinical utility and cost-effectiveness
in this context remain to be established.
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